NFA
HPTX

Nationwide Fund Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Nationwide Fund Advisors’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,524
Closed -$621K – 3446
2015
Q1 		$621K Sell
13,524
-23,042
-63% -$689K ﹤0.01% 2130
2014
Q4 		$878K Buy
36,566
+2,876
+9% +$64.8K ﹤0.01% 1879
2014
Q3 		$850K Buy
33,690
+110
+0.3% +$2.73K ﹤0.01% 1910
2014
Q2 		$876K Buy
33,580
+7,417
+28% +$191K ﹤0.01% 1940
2014
Q1 		$675K Sell
26,163
-64
-0.2% -$1.73K ﹤0.01% 1919
2013
Q4 		$530K Sell
26,227
-134
-0.5% -$3.15K ﹤0.01% 2214
2013
Q3 		$689K Buy
26,361
+15,846
+151% +$397K ﹤0.01% 2056
2013
Q2 		$231K Buy
+10,515
New +$230K ﹤0.01% 2425

Nationwide Fund Advisors's HPTX Position: Q2 2015 in Review

Nationwide Fund Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 13,524 shares — an estimated $621K sold.

Nationwide Fund Advisors first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $878K in Q4 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Nationwide Fund Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Nationwide Fund Advisors sold 13,524 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $621K.
  • Nationwide Fund Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Nationwide Fund Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $878K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Nationwide Fund Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.